AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.672
-0.077 (-10.23%)
Dec 5, 2025, 4:00 PM EST - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $7.95 million as of December 5, 2025. Its market cap has decreased by -67.75% in one year.
Market Cap
7.95M
Enterprise Value
20.28M
1-Year Change
-67.75%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $7.95M, a decrease of -87.50%. That is a compound annual growth rate of -36.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 8.86M | -58.95% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |